Taiwan's 2020 Tang Prize, Asia's equivalent to the Nobel Prize, has been awarded to two British citizens: Jane Goodall in the category of Sustainable Development and Marc Feldmann in the category of Biopharmaceutical Science.
The 2020 Tang Prize in Sustainable Development has been awarded to Jane Goodall, one of the most influential primatologists and pioneering conservationist, for her ground-breaking discovery in primatology that redefines the human-animal relationship, and for her lifelong unparalleled dedication to the conservation of Earth's environment.
The 2020 Tang Prize in Biopharmaceutical Science has been awarded jointly to Marc Feldmann (UK/Australia), Charles Dinarello (US) and Tadamitsu Kishimoto (Japan) for the development of cytokine-targeting biological therapies for the treatment of inflammatory diseases.
The Tang Prize Foundation was founded by Samuel (Yen-Liang) Yin, chairman of Ruentex Group and chief development officer, chief technology officer, and chief engineer of the Ruentex Construction Group. Dr Samuel Yin established the Tang Prize in December 2012 to encourage individuals across the world to chart new paths to achieving sustainable development by recognising and supporting contributors for their work in the four major fields of Sustainable Development, Biopharmaceutical Science, Sinology and Rule of Law. The Tang Prize is global in its reach, with laureates selected on the basis of the originality of their work and their contributions to society, irrespective of their nationality or ethnicity.
For more information on the Tang Prize awarded to Dr Jane Goodall, please see here:
https://www.tang-prize.org/en/owner_detail.php?id=1397&cat=10
For more information on the Tang Prize awarded to Dr Marc Feldmann, please see here:
https://www.tang-prize.org/en/owner_detail.php?id=1403&cat=11
